Cannabis Law Report

SEPTEMBER 9, 2021

WHAT: During the session, “ Cannabis Moves Toward the Mainstream ,” Nielsen will share IRI and BDSA’s predictions for mainstream market opportunities, cannabis ingredients, product development, labeling and safety. . . WHEN: Cross Channel Measurement in a Time of Data Collection Challenges. . 20, 2021, from 2:40 – 2:55 p.m.

Events 102

Events Wellness and Beauty Data Media 102

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Big Data Improves Distribution in the Marijuana Industry. Source: [link]. Global Cannabis Applications Corp.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

AUGUST 3, 2021

(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.

Research and Development 105

Research and Development Data Conditions Therapy 105

NORML

MARCH 7, 2019

Also introduced was The Marijuana Data Collection Act of 2019 , which would study the effects of state legalized medicinal and non-medicinal marijuana programs from a variety of perspectives, including state revenues, public health, substance abuse and opioids, criminal justice, and employment.

Legislation 249

Legislation Marijuana Policy Research and Development 249

Cannabis Law Report

MAY 9, 2022

Preferred candidates will have seven years prior experience in a policy-related management role; experience with professional exposure to the cannabis industry or policy issues related to public health and safety; experience with a strong analytical background and experience working with large data sets.

Policy 52

Policy Research and Development Safety Data 52

Sensi Seeds

DECEMBER 10, 2018

At the same time, research on medical cannabis over the past two decades has not ceased to increase and provide evidence of the plant’s medical value. As a result, medical and scientific research has been highly constrained for many decades. Exponential Increase in Cannabis Research: Trends.

Medicine 81

Medicine Research and Development Data Policy 81

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

United Patients Group

JANUARY 4, 2024

They bridge the gap between technology and healthcare, ensuring the secure and efficient collection, storage, analysis, and utilization of patient data. They work on implementing and maintaining electronic health records (EHRs), developing data-driven solutions, and training healthcare professionals on using technology effectively.

Research and Development 52

Research and Development Patients Data Policy 52

The Cannigma

NOVEMBER 23, 2021

The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects. We delve into how data can further our understanding of different types of cannabis and why standardization is desperately needed in the industry. 0:04:45.2] EG: Yeah, we do.

Data 52

Data Patients Access Wellness and Beauty 52

Cannabis Law Report

JANUARY 4, 2022

Assay and Recently Developed, Unsupervised, At-Home Sample Collection Kit to Expand Addressable Market and Scope of COVID-19 Testing Services – STONY BROOK, N.Y.–(BUSINESS Assay”) as a Laboratory Developed Test (LDT), pending a final review of the assay’s validation data by NYSDOH. Assay (the “Linea 2.0

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

JANUARY 21, 2022

Assay”) and Linea™ Unsupervised At-Home Sample Collection Kit (the “Linea Collection Kit”). The Linea Collection Kit is designed to enable the simple self-collection of nasal swab specimens without supervision by medical personnel. COVID-19 Assay (the “Linea 2.0 Investor Relations Contact: Sanjay M.

Collective 52

Collective Therapy Research and Development Supply Chain 52

Cannabis Law Report

OCTOBER 12, 2021

Mary Hartnett, Director of Medical Services at Sarah Lawrence College, stated, “safeCircle was our choice given the convenience of its on-site sample collection process, access to high-sensitivity RT-PCR-based testing with rapid turnaround times, ability to scale with our needs, and capacity to ease our administrative burdens.

Programs 52

Programs Clinical Trials Research and Development Therapy 52

Cannabis Law Report

MARCH 10, 2022

Breaking from past tradition, this year’s Industrial Hemp Summit was held at the North Carolina Biotechnology Center in the Research Triangle Park. Domestic Hemp Production Program at the U.S. It is clear that he and his staff are committed to the continued growth and development of a viable domestic U.S.

Hemp 52

Hemp Research and Development Supply Chain Data 52

Cannabis Law Report

AUGUST 22, 2021

With decriminalization efforts underway in many other cities and states, this new training, the first of its kind in the US, could set the stage for the design and deployment of programs like it across the country. Interesting piece from Lucid news. Read the full report at .

Research and Development 105

Research and Development Decriminalization Education Safety 105

SpeedWeed

SEPTEMBER 17, 2021

“Wesana is a serious, thoughtful and ethical company engaged in the development of psychedelic-assisted therapy. Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. Lately, MAPS research zeroed in on MDMA-assisted therapy for PTSD.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

The Cannigma

MARCH 2, 2021

This issue is compounded when veterans do, on rare occasions, ask their doctors about medical marijuana, only to be treated as if they are mentally unstable or receive no specific health information at all,” the researchers found. This directly conflicts with past research claiming marijuana increases PTSD symptom severity.”.

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

Cannabis Law Report

NOVEMBER 23, 2021

to provide naturally derived psilocybin for research and development of therapeutic products. “As the research and drug development work on psilocybin moves forward, HAVN Life continues to position itself as a supply chain leader, able to meet the demand for naturally derived psilocybin,” he adds.

Supply Chain 52

Supply Chain Research and Development Pharmaceutical Compliance 52

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.”

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

SEPTEMBER 2, 2021

– Company’s safeCircle™ Testing Program to Monitor for COVID-19 Among On-Campus Unvaccinated Populations –. The Contract contains no minimum testing requirement; it stipulates a fixed monthly fee for sample collection site services and a separate fixed fee per individual COVID-19 test. STONY BROOK, N.Y.–(BUSINESS

Clinical Trials 99

Clinical Trials Research and Development Therapy Collective 99

Cannabis Law Report

JUNE 30, 2021

s (CSE: MXT) (OTC: MXTTF) SHAMAN and YMI programs apply machine learning to high-resolution health records to better diagnose mental health disorders. For example, research shows that primary care physicians misdiagnosed 65.9% Researchers are just starting to uncover the potential for psychedelics to treat mental health disorders.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Program between St. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

AUGUST 18, 2022

One year after the United States Department of Agriculture (USDA) issued its final rules on hemp, various states enacted their own regulatory programs. With that research, they created elaborate matrices to compare each mandate. BOCA RATON, Fla., Aixia Sun, ACS Laboratory conducted intense due diligence for several months.

Compliance 52

Compliance Compliance Hemp Research and Development 52

Cannabis Law Report

SEPTEMBER 9, 2021

The current public policies in local and state cannabis ordinance and equity programs may enhance racial disparities if they follow the pattern of exclusion and criminalization that encompass past policies promoted as beneficial to African Americans but uphold racial capitalistic practices. Central Research Question. Recommendations.

Policy 105

Policy Research and Development Collective Banking 105

Cannabis Law Report

JULY 23, 2021

The bill includes several provisions for additional research to investigate the impact of legalization on public health, driving safety, and similar areas. Research, Training and Prevention. Cannabis research has been limited up to this point due to its status as a Schedule 1 controlled substance.

Research and Development 105

Research and Development DEA Programs State Laws 105

SpeedWeed

AUGUST 11, 2021

According to Dr. Sue Sisley, President of the Scottsdale Research Institute and longtime cannabis researcher, this new study is sorely needed in the community. Veterans are demanding objective cannabis drug development research, and the state of Michigan is fulfilling our collective obligation to our beloved Veteran community.”.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Cannabis Law Report

JULY 28, 2021

MAPS Public Benefit Corporation (MAPS PBC) catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics prioritizing public benefit above profit. Support Regulatory Affairs in the planning, development, and publishing of submissions.

Clinical Trials 105

Clinical Trials Research and Development Data Environment 105

Cannabis Law Report

JUNE 24, 2021

Gather robust data and share it widely. Reduce stigma through proactive programs. Support cannabis career development opportunities. Homegrow and medical cannabis programs are the two most popular cannabis equity strategies employed by states. Safeguard rights and accessibility for medical patients. Methodology.

Legalization 76

Legalization Data eCommerce Policy 76

Cannabis Law Report

AUGUST 28, 2019

The company benefits from a 365-day cultivation window and has developed proprietary hemp strains tailored for the region alongside state-of-the-art processing and extraction facilities. The Agronomic Research and Data Collection research program is designed to optimize quality and yield of hemp grown in the Imperial Valley. .

Hemp 45

Hemp Research and Development Extraction Cultivation 45

Cannabis Law Report

JUNE 2, 2021

Samples will be collected via anterior nasal swabs that offer ease-of-use for all ages. About safeCircle™ ADCL’s pooled surveillance testing program, known as safeCircle™, utilizes frequent, high-sensitivity pooled testing to help prevent virus spread by quickly identifying infections within a community, school, or workplace.

Clinical Trials 82

Clinical Trials Therapy Research and Development Collective 82

Cannabis Law Report

FEBRUARY 13, 2022

The practice of collecting defensive secretions from toad parotoid glands isn’t a pretty sight. While there is no empirical data to prove that is true, the jury is still out over whether an entourage effect encompassing all the compounds in toad venom make it a superior option. But this kind of transcendence comes at a cost.

Research and Development 52

Research and Development Wellness and Beauty Agriculture Collective 52

Cannabis Law Report

AUGUST 3, 2021

The Contract specifies ADCL’s deployment of safeCircle™, its high-throughput, pooled COVID-19 testing program, to provide weekly asymptomatic diagnostic COVID-19 screening of on-campus unvaccinated students, staff, and faculty, and a random sampling of vaccinated individuals across the CUNY school system.

Clinical Trials 105

Clinical Trials Therapy Collective Research and Development 105

Cannabis Law Report

SEPTEMBER 1, 2021

While Wednesday’s $2 billion sales milestone does account for initial delivery sales conducted via the three operating licensees, the Commission is not parsing out specific data at this time to maintain driver safety. This past May, the Commission launched the license application for Marijuana Delivery Operators.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

SpeedWeed

APRIL 2, 2021

Amanda McComb: We started our cannabis banking program in 2015 and have since gone through 15 state and federal exams. So, it’s been a long haul, most specifically just for the cannabis program to make sure that we were staying in compliance and doing it in a safe and sound way.

Education 52

Education Banking Hemp Compliance 52

Cannabis Law Report

JANUARY 18, 2022

ADCL’s safeCircle program is a fully integrated testing platform for enterprise and educational institutions that provides a full range of COVID-19 diagnostic testing and associated services, including sample collection, test site infrastructure design and management, results tracking, and vaccination status management. Dr. James A.

Research and Development 52

Research and Development Therapy Supply Chain Collective 52

Cannabis Law Report

MAY 26, 2022

Researchers sent out undercover patrons who looked underage to 50 randomly selected dispensaries in California to see if they could get weed without first furnishing an ID, as required. All dispensaries involved passed the test, which researchers admitted was “somewhat surprising.”. Journal of Safety Research. 1988, Jones et al.,

Dispensary 52

Dispensary Research and Development Safety Recreational 52

Cannabis Law Report

MARCH 2, 2020

to my knowledge, there are no state-governed collection programs built into medical cannabis policy, compliance, legal or tax frameworks, or end user means of disposal. Further development and industrialisation of alternative tecnologies will enable the industry to deliver zero-waste turbines.” We can always hope.

Vaping 59

Vaping Collective Research and Development Packaging 59

Cannabis Law Report

JUNE 15, 2021

. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.

Decriminalization 78

Decriminalization Policy Research and Development Data 78